Metadone Cloridrato Molteni

Methadone Hydrochloride, the active ingredient in Metadone Cloridrato Molteni, is an opioid presented as an oral dosage form for oral use. It is employed in the management of severe chronic pain and in opioid dependence maintenance therapy. It is classified as a Schedule II controlled substance and is available only by prescription.

GNH USA supplies Metadone Cloridrato Molteni as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to EU GMP standards and providing the product to hospitals, pharmacies and clinics worldwide.

Methadone Hydrochloride acts on the opioid system to provide analgesia and to stabilize opioid dependence. - Severe chronic pain: delivers long‑acting analgesia to reduce persistent pain intensity. - Opioid dependence maintenance: suppresses withdrawal symptoms and cravings in patients undergoing substitution therapy. - Palliative care: offers sustained pain relief for patients with advanced disease where other opioids are insufficient.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: sensation of queasiness, often transient. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivary flow causing oral discomfort. - Sweating: excessive perspiration unrelated to temperature. - Mood changes: irritability or mild anxiety.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - Cardiac arrhythmia: abnormal heart rhythm, especially QT prolongation. - Severe hypotension: marked drop in blood pressure causing dizziness. - Seizures: convulsive episodes, particularly at high doses. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Dependence and abuse: risk of addiction with prolonged use.

Methadone Hydrochloride requires careful monitoring due to its potency and potential for dependence. - Initiation: start at low doses and titrate slowly under medical supervision. - Monitoring: regular assessment of respiratory function, cardiac status, and liver function. - Interactions: avoid concurrent use with other central nervous system depressants. - Pregnancy: use only if benefits outweigh risks; consult a specialist. - Storage: Store below 25°C: keep in the original container, protect from moisture and light.

Methadone Hydrochloride can interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid): - Benzodiazepines: combined use may cause profound respiratory depression. - MAO inhibitors: can precipitate hypertensive crisis or serotonin syndrome. - QT‑prolonging agents: increase risk of cardiac arrhythmia.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may raise methadone plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce methadone effectiveness. - CNS depressants (e.g., alcohol, antihistamines): enhance sedative effects.